Form-4 Alert & More

Options Review 

We closed out the trading week on Friday morning with some fresh options ideas, namely the SPLK Weekly $134-138 Calls. The moves we observed in those contract sets were highly impressive, with enormous multi-bag runs across the board.

The total possible profits on the table for daytraders were as follows:

$134 CallsRange: 1.79-6.50 – Max Gain: 263%
$135 Calls – Range: 1.15-5.80 – Max Gain: 404%
$136 Calls – Range: .83-5.70  – Max Gain: 586%
$137 Calls – Range: .50-3.70 – Max Gain: 640%
$138 Calls – Range: .26-2.74  – Max Gain: 954%

Cheers to anyone who took advantage of this unbelievable quick-strike opportunity!


Ebix, Inc. EBIX – Form-4 Alert

We caught a Form-4 insider buying alert on EBIX this morning. That’s when we noticed the prime bottom positioning of the chart, complete with a significant gap to the topside. This will be a perfect candidate to identify some longer-term options plays we have interest in tracking.

We’ll be looking at the EBIX 03/20 $30-40 Calls in the days and weeks ahead.


Extended Watchlist:
ANAB, SAML, ATNM, TEVA, ICPT, ZGNX, CYIO, SAML

Blue Horseshoe Stocks: SNTA Recap, Options & More

Synta Pharmaceuticals Corp. SNTA

After catching a PR containing some big merger news for SNTA yesterday morning, we decided to include the stock in our premarket report, and it turned out to be a good decision.

On just under 12X the 3-month average trading volume, SNTA ran from a daily low of .32 up to .45 inside of the first 90 minutes of the session. That registered as a respectable intraday spike of 41% As measured to this morning’s premarket high of .488, that figure is extended to 53%

We’ll have our eyes peeled for another push this morning. The type of volume that we witnessed yesterday coupled with the stock holding more than 50% of its daily gains, puts SNTA into the category of a possible momentum play.

______

Bonus Pharma Watchlist:

We are also going to be monitoring the activity in a couple of other pharma stocks in coming sessions:  Aoxing Pharmaceutical Co., Inc. AXN and Eleven Biotherapeutics, Inc. EBIO

EBIO is reportedly another reverse-merger candidate that caught a wave of momentum on the heels of yesterday’s big news, and AXN is showing a double-bottom signal and has been making headway trading up off of its lows for the past few sessions. We’ll want to monitor both of these plays into next week.


SPDR S&P 500 ETF (SPY) – Fresh Options Idea

It wouldn’t be a typical Friday without a end-of-week options idea, so we’re going to turn to one of our classic targets- the SPY. Here in the premarket we’ve observed a low of 207.58. How we’ll want to play it is this: Should the SPY maintain support at 207.50 or above on any early pullbacks, we’re going to be interested in the Weekly $207.50-208 Calls. In the event it fails to hold support a that point, we’ll look to the Weekly $208-207.50 Puts.

*CAUTION: Trading weekly options on Friday is commonly a very high risk proposition. To be attempted by advanced traders only!


Extended Watchlist:
SUNE, LNCO, LINE, VSLR, EBIX, DRWI, AXPW(Bottom-Watcher)